You are here

VRTX

$161.97

0.00%

Investor Relations

Analyst Coverage

Vertex Pharmaceuticals is covered by the following analysts.

Analyst Coverage
Firm Analyst
Baird
Brian Skorney
Bank of America Merrill Lynch
Ying Huang, Ph.D.
Barclays
Geoffrey Meacham, Ph.D.
BMO Capital Markets
Do Kim
Citi Research
Robyn Karnauskas, Ph.D.
Cowen & Co.
Phil Nadeau, Ph.D.
Credit Suisse
Alethia Young
Goldman Sachs
Terence Flynn, Ph.D.
Guggenheim Securities
Tony Butler, Ph.D.
HC Wainwright
Andrew Fein
J.P. Morgan
Cory W. Kasimov
Janney Capital Markets
Kimberly Lee, DO
JMP Securities
Liisa Bayko
Leerink
Geoff Porges, Ph.D.
Maxim Group
Jason McCarthy
Morgan Stanley
Matthew Harrison
Needham & Company
Alan Carr, Ph.D.
Oppenheimer
Hartaj Singh
Piper Jaffray
Edward Tenthoff
Raymond James
Christopher Raymond
Stifel
Adam Walsh, Ph.D.
William Blair
Katherine Xu

Please note that any opinions, estimates or forecasts regarding Vertex Pharmaceuticals's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vertex Pharmaceuticals or its management. Vertex Pharmaceuticals does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.